LimI.G., BertouchJ.V.Remission of lymphoma after drug withdrawal in rheumatoid arthritis. Med J Aust2002; 177(9): 500–501.
2.
BairdR.D., van Zyl-SmitR.N., DilkeT., ScottS.E., RassamS.M.Spontaneous remission of low-grade B-cell non-Hodgkin's lymphoma following withdrawal of methotrexate in a patient with rheumatoid arthritis: case report and review of the literature. Br J Haematol2002; 118(2): 567–568.
3.
BrownS.L., GreeneM.H., GershonS.K., EdwardsE.T., BraunM.M.Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration. Arthritis Rheum2002; 46(12): 3151–3158.
4.
SternR.S., LairdW.The carcinogenic risk of treatments for severe psoriasis. Cancer1994; 73: 2759–2764.
5.
StackW.A., RichardsonP.D., LoganR.P., MahidaY.R., HawkeyC.J.Nocardia asteroides lung abscess in acute ulcerative colitis treated with cyclosporine. Am J Gastroenterol2001; 96(7): 2255–2256.
6.
CainelliF., ConciaE., VentoS.Cryptococcal meningitis during cyclosporin treatment in a patient with psoriasis. Br J Dermatol2000; 143(6): 1327–1328.
7.
CurseifenC., GrunkeM., DechantC., AntoniC., JunemannA., HolbachL.M.Multiple bilateral eyelid molluscum contagiosum lesions associated with TNF alpha-antibody and methotrexate therapy. Am J Ophthalmol2002; 134(2): 270–271.
8.
TrueD.G., PenmetchaM., PeckhamS.J.Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab. J Rheumatol2002; 29(7): 1561–1563.
9.
KeaneJ., GershonS., WiseR.P., Mirabile-LevensE., KasznicaJ., SchwietermanW.D., SiegelJ.N., BraunM.M.Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med2001; 345(15): 1098–1104.
10.
SlifmanN.R., GershonS.K., LeeJ.H., EdwardsE.T., BraunM.M.Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents. Arthritis Rheum2003; 48(2): 319–324.
11.
HelblingD., BreitbachT.H., KrauseM.Disseminated cytomegalovirus infection in Crohn's disease following anti-tumour necrosis factor therapy. Eur J Gastroenterol Hepatol2002; 14(12): 1393–1395.
MatzkiesF.G., MangerB., Schmitt-HaendleM., NagelT., KraetschH.G., KaldenJ.R., Schulze-KoopsH.Severe septicaemia in a patient with polychondritis and Sweet's syndrome after initiation of treatment with infliximab. Ann Rheum Dis2003; 62(1): 81–82.
